|
Volume 271,
Number 8,
Issue of February 23, 1996 pp. 4243-4250
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Influence of
Sphingomyelin on the Structure and Function of Reconstituted High
Density Lipoproteins (*)
(Received for publication, July 18, 1995; and in revised form, October 30, 1995)
Kerry-Anne
Rye
(1), (§),
Neil J.
Hime
(2),
Philip
J.
Barter
(2)From the
(1)Division of Cardiovascular Services and
(2)University of Adelaide, Department of Medicine,
Royal Adelaide Hospital, Adelaide, South Australia, Australia 5000
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The effect of sphingomyelin (SPM) on the structure and function
of discoidal and spherical reconstituted high density lipoproteins
(rHDL) has been studied. Three preparations of discoidal rHDL with
1-palmitoyl-2-oleoyl phosphatidylcholine (POPC)/SPM/unesterified
cholesterol (UC)/apolipoprotein (apo)A-I molar ratios of
99.6/0.0/10.2/1.0, 86.0/13.6/10.8/1.0, and 72.5/26.3/11.4/1.0 were
prepared by cholate dialysis. SPM did not affect discoidal rHDL size or
surface charge. Esterification of cholesterol by lecithin:cholesterol
acyltransferase (LCAT) was inhibited in the SPM-containing discoidal
rHDL. When the discoidal rHDL of POPC/SPM/UC/apoA-I molar ratio
99.6/0.0/10.2/1.0 were incubated with low density lipoproteins (LDL)
and LCAT, SPM transferred spontaneously from the LDL to the rHDL (t = 0.8 h) and spherical particles with
a POPC/SPM/UC/CE/apoA-I molar ratio of 24.6/4.9/3.6/24.9/1.0 were
formed. Depleting the spherical rHDL of SPM head groups by incubation
with sphingomyelinase increased the negative charge on the surface, but
did not change their size. Cholesteryl ester transfer protein
(CETP)-mediated transfers of cholesteryl esters and triglyceride
between spherical rHDL and Intralipid were not affected by SPM head
group depletion. The effect of SPM on rHDL structure was assessed
spectroscopically. SPM increased POPC acyl chain and head group packing
in the discoidal rHDL. When the spherical rHDL were depleted of SPM
head groups, POPC acyl chain packing order decreased, but head group
packing order was not affected. SPM inhibited the lipid-water
interfacial hydration of discoidal rHDL. This parameter was not
affected when the spherical rHDL were depleted of SPM head groups. The
SPM molecule and the SPM head group, respectively, inhibited the
unfolding of apoA-I in discoidal and spherical rHDL. It is concluded
that (i) SPM influences the structure of discoidal and spherical rHDL,
(ii) SPM inhibits the LCAT reaction in discoidal rHDL, and (iii) the
SPM head group does not affect CETP-mediated lipid transfers into or
out of spherical rHDL.
INTRODUCTION
Sphingomyelin (SPM) ( )is a glycosphingolipid which is
present in cell membranes and plasma lipoproteins. For many years SPM
was thought only to maintain the structural integrity of membranes, but
recent studies have shown that it is also involved in a wide range of
metabolic events(1, 2) . The SPM molecule comprises a
phosphocholine head group and a ceramide backbone with a sphingosine
base and an amide-linked acyl chain. The ceramide backbone of SPM plays
a regulatory role in cell growth, differentiation, and
apoptosis(1, 2) . Ceramide also modulates protein
phosphorylation and has been implicated as a tumor-suppressor lipid (3) . The influence of SPM on lipoprotein metabolism is poorly
understood. It has been reported that the concentration of SPM in the
artery wall increases with aging and that it comprises 70-80% of
the phospholipids in atherosclerotic lesions(4) . These
observations suggest that SPM may be involved in the development of
atherosclerosis. The additional finding that the SPM in atherosclerotic
lesions is derived from plasma lipoproteins (4) emphasizes the
importance of understanding how this molecule influences lipoprotein
metabolism. At present little is known about the origin of SPM in
lipoproteins. SPM reportedly transfers from cell membranes to
pre- -migrating high density lipoproteins (HDL)(5) . SPM is
also present in discoidal, nascent HDL which are secreted from the rat
liver(6) . However, it is not known whether the SPM, which
enters the plasma compartment as a component of pre- -migrating HDL
and nascent HDL, is subsequently incorporated into mature, spherical
HDL. Similarly, little is known of the origins of SPM in low density
lipoproteins (LDL) and very low density lipoproteins. It has been
reported that the lipoproteins in peripheral lymph are enriched in SPM
relative to their plasma counterparts(7) , suggesting that SPM
from cell membranes may be incorporated into lipoproteins before they
enter the plasma compartment. Given that there are strong Van der
Waals interactions between SPM and unesterified cholesterol (UC) (8, 9) and that the concentrations of UC and SPM in
membranes and lipoproteins change in a coordinated manner (10) , it follows that SPM may participate in the regulation of
cholesterol transport and the maintenance of cell cholesterol
homeostasis. Evidence for this comes from studies which show that SPM
regulates the uptake and intracellular processing of
LDL(11, 12) . The additional finding that
SPM-containing lipid/apolipoprotein complexes are excellent acceptors
of cellular cholesterol (13) suggests that SPM may also be
involved in the initial step of the reverse cholesterol transport
process. Further support for the involvement of SPM in reverse
cholesterol transport comes from the observation that
[ H]cholesterol efflux from fibroblasts to HDL
increases if the cells have been incubated with
sphingomyelinase(10) . The aim of the present study is to
better understand the influence of SPM on HDL metabolism. In order to
overcome the problems of interpretation which may occur due to the
heterogeneity of native HDL, the study has been carried out with well
characterized preparations of discoidal and spherical reconstituted HDL
(rHDL)(14, 15) . The results show that SPM influences
both the structure and function of rHDL.
EXPERIMENTAL PROCEDURES
Isolation of HDL, LDL, and Apolipoprotein (Apo)
A-IPlasma samples for the isolation of LDL, HDL and apoA-I were
donated by the Transfusion Service, Royal Adelaide Hospital. LDL and
HDL were isolated in the 1.019 < d < 1.055 and 1.07 <
d < 1.21 g/ml density range, respectively(16) . ApoA-I was
prepared by delipidating HDL (17) and anion exchange
chromatography of the resulting apoHDL on Q Sepharose Fast Flow
(Pharmacia Biotechnology AB, Uppsala, Sweden) (18) .
Preparation of Discoidal and Spherical rHDLUC,
1-palmitoyl-2-oleoyl phosphatidylcholine (POPC), egg yolk SPM, and
sodium cholate were purchased from Sigma. Discoidal rHDL were prepared
by the cholate dialysis method(19) . Discs containing SPM were
prepared by drying POPC, SPM, and UC onto the walls of glass test
tubes, then proceeding as previously described(19) . When the
discoidal rHDL were used as substrates for the lecithin:cholesterol
acyltransferase (LCAT) reaction, [ H]UC (48
Ci/mmol) (Amersham International, Buckinghamshire, UK) was added to the
lipids before drying. The resulting particles contained approximately
48,000 cpm/nmol UC. Lipid-free apoA-I was not present in the discoidal
rHDL preparations as judged by nondenaturing gradient gel
electrophoresis and staining with Coomassie Blue. Spherical rHDL were
prepared by incubating discoidal rHDL with LDL and LCAT as described
previously(20) . Before use, all of the rHDL preparations were
dialyzed extensively against 0.01 M Tris-buffered saline (TBS)
(pH 7.4) containing 0.15 M NaCl, 0.005% (w/v)
EDTA-Na , and 0.006% (w/v) NaN .
Purification of LCATLCAT was isolated from 2
liters of human plasma (Transfusion Service, Royal Adelaide Hospital)
by precipitation with ammonium sulfate and citric acid followed by
ultracentrifugation at a density of 1.25 g/ml(21) . The d > 1.25 g/ml fraction was applied to an XK 50/60 column
containing phenyl-Sepharose 6 Fast Flow (high substitution) (Pharmacia)
which had been preequilibrated with 3 M NaCl. LCAT was eluted
from the column with Milli Q water at a flow rate of 10 ml/min. The
active fractions were pooled, dialyzed against 20 mM Tris (pH
7.4), and applied to a preequilibrated XK 26/40 column packed with DEAE
Sepharose Fast Flow (Pharmacia). LCAT was eluted from the column with
20 mM Tris, 160 mM NaCl (pH 7.4) at a flow rate of 10
ml/min, and the active fractions were pooled. These steps were carried
out at room temperature on a fast protein liquid chromatography system
(Pharmacia). The purified LCAT appeared as a single band following
electrophoresis on a 20% homogeneous SDS-gel and staining with
Coomassie Blue. Activity was assessed as described by Piran and Morin (22) using [ H]UC-labeled POPC/UC/apoA-I
discoidal rHDL as a substrate. The assay was linear if less than 30% of
the [ H]UC was esterified. The preparation used in
this study generated 227 nmol of cholesteryl esters (CE)/ml LCAT/h.
Purification of Cholesteryl Ester Transfer Protein
(CETP)CETP was prepared as described previously(23) .
Transfer activity was assessed as the transfer of
[ H]CE from [ H]CE-HDL to LDL(24, 25) . The assay was linear if less
than 30% of the [ H]CE transferred from HDL to LDL. Activity is expressed in units, with 1 unit being the
transfer activity of 1 ml of a preparation of pooled, human
lipoprotein-deficient plasma. The preparation of CETP used for this
study had 6 units of activity/ml.
IncubationsUnless stated otherwise, all
incubations were carried out in stoppered plastic tubes in a shaking
water bath maintained at 37 °C. Nonincubated controls were stored
at 4 °C. Details of individual incubations are described in the
legend to the figures. Incubations with sphingomyelinase from Bacillus cereus (Boehringer Mannheim) were carried out for 1 h
at 37 °C using 1.4 units of sphingomyelinase/mg
apoA-I(26) . As EDTA-Na inhibits
sphingomyelinase(26) , the rHDL were dialyzed against TBS
without EDTA-Na before incubation. When the incubations
were complete the rHDL were dialyzed extensively against TBS with
EDTA-Na .The rHDL were isolated from incubation mixtures
by ultracentrifugation at 100,000 rpm in the 1.07 < d <
1.25 g/ml density range using a TLA-100.4 rotor or in the 1.063 < d < 1.25 g/ml density range using a TLA-100.2 rotor. Two
16-h spins at the lower density and one 16-h spin at the higher density
were performed. These procedures were carried out at 4 °C in a
Beckman TL-100 tabletop ultracentrifuge. The rHDL were dialyzed
extensively against TBS before use.
ElectrophoresisAgarose-gel electrophoresis was
carried out as described previously(15) . Electrophoretic
mobilities were calculated by dividing electrophoretic velocity
(migration distance (µm/time (s)) by the electrophoretic potential
(voltage (V)/length of gel (cm))(27) . Mobilities were
corrected for pI-dependent retardation as follows(27) .

Nondenaturing gradient gel electrophoresis on 3/35% gels
(Gradipore, Sydney, Australia) was carried out as described previously (28) .
Spectroscopic StudiesThese studies were carried
out with a Perkin-Elmer LS-50 luminescence spectrometer fitted with a
thermostatted cell holder and polarizers. Sample temperatures were
controlled by a Lauda RM6T recirculating water bath
(Lauda-Königshofen, Germany) and monitored with a
digital temperature probe (Baker Medical Research Institute, Melbourne,
Australia).Packing of rHDL phospholipid head groups and acyl chains
was monitored by labeling with
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluene sulfonate (TMA-DPH) and
1,6-diphenyl-1,3,5-hexatriene (DPH),
respectively(29, 30) . Polarity of rHDL lipid-water
interfacial regions was assessed with
6-propionyl-2-(dimethylamino)-naphthalene (PRODAN)(31) . In all
cases the molar ratio of phospholipid/probe was 500/1, and the
phospholipid concentration was 0.5 mM. The labeling procedures
and spectroscopic conditions are described in detail
elsewhere(15) . The unfolding of apoA-I was assessed from
the wavelength of maximum fluorescence of samples following incubation
at 25 °C for 0, 2, 5, 7, and 24 h with 0-8 M guanidine hydrochloride (GdnHCl). Data from the 24-h time points
were used for the calculations described below. All calculations are
based on the assumption that the unfolding of apoA-I is represented by
a two-state process such that, at a given time, the only species
present at significant concentrations are either completely folded or
completely unfolded(32) . The central, linear regions of the
unfolding curves were used for the calculations. For a given
concentration of GdnHCl, the fraction of unfolded apoA-I was calculated
as

where y , y , and y represent the respective wavelengths of maximum fluorescence in
the folded, unfolded, and transition states. The equilibrium
constant (K) for unfolding was calculated as

and the free energy change was calculated
as

where R is the gas constant (1.987 cal/degree/mol) and T is the absolute temperature (198.15 K). The concentration of
GdnHCl at the midpoint of the denaturation curve was calculated from
plots of G versus the concentration of GdnHCl using
values of G between -1.5 and +1.5 kcal/mol.
G where n is the difference in the number of binding
sites between the folded and unfolded states, k is the
equilibrium constant for binding at each site (0.6), and a,
the activity of GdnHCl, is calculated from the molarity (M) of
GdnHCl as follows

Chemical AnalysesAll assays were carried out
on a Cobas Fara Centrifugal Analyser (Roche Diagnostics, Zurich,
Switzerland). Boehringer Mannheim kits were used for phospholipid, UC,
and total cholesterol assays. Esterified cholesterol concentrations
were calculated as the difference between the total and UC
concentrations. The concentration of apoA-I was measured by an
immunoturbidometric assay(33) . SPM concentrations were
determined as described by Bradley et al.(34) .
Statistical AnalysesThe Student's t test for paired samples was used to determine whether differences
between values were significant.
RESULTS
Effect of SPM on the Physical and Spectroscopic
Properties of Discoidal and Spherical rHDL (Fig. 1, Fig. 2, and Fig. 3, and Table 1)Discoidal
rHDL containing apoA-I, UC, and varying amounts of POPC and SPM were
prepared as described under ``Experimental Procedures.'' The
resulting particles had SPM/apoA-I molar ratios of 0/1, 13.6/1, and
26.3/1. The corresponding POPC/apoA-I molar ratios were 99.6/1, 86.0/1,
and 72.5/1 (Table 1). SPM had little effect on rHDL size, with
all the preparations containing a major population of particles 10.0 nm
in diameter (Fig. 1). The discs with SPM/apo A-I molar ratios of
0/1 and 13.6/1 also contained minor populations of larger particles.
The larger particles were less apparent in the rHDL which had an
SPM/apo A-I molar ratio of 26.3/1.
Figure 1:
Influence of SPM on
the size of discoidal and spherical rHDL. Discoidal and spherical rHDL
with varying amounts of SPM were prepared as described under
``Experimental Procedures,'' electrophoresed on 3/35%
polyacrylamide nondenaturing gradient gels, and stained with Coomassie
Blue G-250. Laser densitometric scans of the stained gels are
shown.
Figure 2:
Kinetics of the transfer of SPM from LDL
to rHDL. Discoidal rHDL (SPM/apoA-I molar ratio = 0/1; final
apoA-I concentration, 0.4 mg/ml) were incubated at 37 °C for 0, 1,
3, 6, 12, or 24 h with LDL (final apoB concentration, 1.5 mg/ml) and
LCAT (1.9 ml). The incubation mixtures also contained bovine serum
albumin (final concentration, 60 mg/ml) and -mercaptoethanol
(final concentration, 4.0 mM). The final volume of the
incubation mixtures was 5.0 ml. When the incubations were complete, the
rHDL were isolated by ultracentrifugation in the 1.07 < d < 1.25 g/ml density range. Concentrations of SPM and apoA-I
were determined as described under ``Experimental
Procedures.'' Molar ratios were calculated from means of
triplicate determinations which varied by less than 10%. The values in
the figure represent the mean of two separate
experiments.
Figure 3:
Influence of SPM on the structure of
discoidal and spherical rHDL. Discoidal rHDL with SPM/apoA-I molar
ratios of 0/1 ( ), 13.6/1 ( ), and 26.3/1 ( ) and
spherical rHDL with SPM/apoA-I molar ratios of 0/1 ( ) and 4.9/1
( ) were labeled with DPH (Panel A), TMA-DPH (Panel
B), and PRODAN (Panel C). Steady state fluorescence
polarization of the DPH- and TMA-DPH-labeled samples and the wavelength
of maximum fluorescence of the PRODAN-labeled samples are shown. Values
represent the mean of at least three determinations. Experimental
errors for the polarization values are ±0.003 and ±1.0 nm
for the wavelength of maximum fluorescence.
When these discoidal rHDL
preparations were incubated with LDL and LCAT, the resulting spherical
rHDL all had SPM/apoA-I molar ratios of approximately 5/1 (result not
shown). This was consistent with SPM transferring spontaneously between
LDL and rHDL. The kinetics of the transfer of SPM from LDL to rHDL was
investigated by incubating discoidal rHDL with a POPC/SPM/UC/apoA-I
molar ratio of 99.6/0.0/10.2/1.0 in the presence of LDL and LCAT for
0-24 h. The rHDL were then isolated by ultracentrifugation and
the molar ratio of SPM/apoA-I was determined (Fig. 2). The
SPM/apoA-I molar ratio increased rapidly during the first hour of
incubation. Equilibrium was achieved between 6 and 12 h, with a t for the transfer of 0.8 h. After 24 h of
incubation, the POPC/SPM/UC/CE/apoA-I molar ratio of the spherical rHDL
was 24.6/4.9/3.6/24.9/1.0. In molar terms, SPM accounted for 17% of the
phospholipid in the spherical rHDL (Table 1). When the
spherical rHDL were depleted of SPM head groups by incubation with
sphingomyelinase, the concentrations of the other constituents and the
size of the particles did not change ( Fig. 1and Table 1).
This was not the case for the SPM-containing discoidal rHDL, which were
converted quantitatively to larger and smaller particles by incubation
with sphingomyelinase (result not shown). These larger and smaller
particles were not further characterized. Various spectroscopic
techniques were used to assess the effect of SPM on rHDL structure. The
discoidal and spherical rHDL had comparable wavelengths of maximum
fluorescence (Table 1). This is consistent with the environment
of apoA-I Trp residues not being affected by (i) the shape of the rHDL,
(ii) the presence of SPM in discoidal rHDL, or (iii) removal of SPM
head groups from spherical rHDL by incubation with sphingomyelinase.
The wavelengths of maximum fluorescence for the apoA-I in the rHDL were
blue-shifted relative to lipid-free apoA-I. In other words, the apoA-I
Trp residues in the rHDL are in a more hydrophobic environment than
those in lipid-free apoA-I. This is in agreement with what has been
reported elsewhere(23, 35) . The local rotational
motions of the rHDL apoA-I Trp residues were determined by steady state
fluorescence polarization (Table 1). Although the discoidal rHDL
polarization values decreased as the SPM content of the particles
increased, the differences were not statistically significant. This is
consistent with SPM having little effect on the local rotational
motions of the apoA-I Trp residues in discoidal rHDL. The polarization
of the spherical rHDL which contained SPM was comparable to that of the
discoidal rHDL, suggesting that particle shape does not affect the
rotation of apoA-I Trp residues. However, the polarization decreased
when the spherical rHDL were depleted of SPM head groups (p < 0.01). This is consistent with the SPM head group restricting
the rotation of apoA-I Trp residues in spherical rHDL. In all cases the
polarization of lipid-associated apoA-I was significantly lower than
that of lipid-free apoA-I (p < 0.001). In other words,
lipid association enhances local rotational motions of apoA-I Trp
residues. This confirms what has been reported
previously(23, 35) . The effect of SPM on rHDL
surface charge was assessed by agarose gel electrophoresis. The
electrophoretic mobilities of the discoidal rHDL were intermediate
between lipid free apoA-I and native HDL and were not affected by SPM (Table 1). This demonstrates that the SPM molecule does not
influence the surface charge of discoidal rHDL. The spherical rHDL with
intact SPM migrated slightly slower than native HDL, but more rapidly
than discoidal rHDL. After incubation with sphingomyelinase, their
electrophoretic mobility increased and was indistinguishable from that
of native HDL. This is consistent with the SPM head group decreasing
the negative charge on the spherical rHDL surface. The influence of
SPM on phospholipid acyl chain packing order was assessed from the
polarization of DPH-labeled spherical and discoidal rHDL (Fig. 3A). The SPM molecule increased discoidal rHDL
acyl chain packing order as evidenced by the increase in polarization
values with increasing SPM/apoA-I molar ratios. The polarization of the
spherical rHDL which had been incubated with sphingomyelinase (open
circles) was slightly lower than that of the spherical rHDL which
had been incubated with TBS (closed circles). This is
consistent with the SPM head group having a minor ordering effect on
spherical rHDL phospholipid acyl chains. The additional finding that
spherical rHDL have higher polarization values than discoidal rHDL
demonstrates that phospholipid acyl chains are more ordered in spheres
than in discs. This is in agreement with what has been reported by
Jonas et al.(35) . Phospholipid head group packing
order was assessed from the polarization of TMA-DPH-labeled discoidal
and spherical rHDL (Fig. 3B). The order of the
discoidal rHDL phospholipid head groups increased as the SPM/apoA-I
molar ratio increased from 0/1 (closed squares) to 13.6/1 (open squares) to 26.3/1 (diamonds). The values for the
spherical rHDL with (closed circles) and without (open
circles) SPM head groups were comparable. The additional finding
that spherical rHDL have more ordered phospholipid head groups than
discoidal rHDL confirms what has been reported elsewhere(35) . The rHDL were also labeled with PRODAN, a polarity sensitive
fluorescent probe (Fig. 3C). The wavelength of maximum
fluorescence of the discoidal rHDL increased rapidly at temperatures
above 25 °C. The increase was greatest for the discs without SPM
(SPM/apoA-I molar ratio = 0/1) (closed squares),
intermediate when the SPM/apoA-I molar ratio was 13.6/1 (open
squares) and least when the SPM/apoA-I molar ratio was 26.3/1 (diamonds). In other words, SPM inhibits the hydration of
discoidal rHDL lipid-water interfacial regions. The wavelength of
maximum fluorescence of PRODAN in the spherical rHDL was comparable
after incubation in the presence (open circles) and absence (closed circles) of sphingomyelinase. This demonstrates that
SPM head groups do not influence the hydration of the spherical rHDL
lipid-water interface. As the increase in the wavelength of maximum
fluorescence of the spherical rHDL was small, it seems that the
lipid-water interface of these particles is resistant to hydration.
Effect of SPM on the Unfolding and Conformational
Stability of ApoA-I in rHDL ( Fig. 4and Fig. 5, and Table 2)The influence of SPM on the unfolding of apoA-I
was assessed by incubating aliquots of discoidal and spherical rHDL for
varying times with increasing concentrations of GdnHCl. The wavelength
of maximum fluorescence of apoA-I was determined at 0, 2, 5, 7, and 24
h. For clarity, only the values for 0 (squares), 2 (closed
circles), and 24 h (open circles) are shown (Fig. 4). Panels A, B, and C,
respectively, show the results for discoidal rHDL with SPM/apoA-I molar
ratios of 0/1, 13.6/1, and 26.3/1. The results for spherical rHDL with
SPM/apoA-I molar ratios of 0/1 and 4.9/1 are in Panels D and E, respectively. The unfolding of lipid-free apoA-I is shown
in Panel F.
Figure 4:
Influence of SPM on the GdnHCl-mediated
unfolding of apoA-I in discoidal and spherical rHDL. Discoidal and
spherical rHDL and lipid-free apoA-I were incubated with increasing
concentrations of GdnHCl for 0 ( ), 2 ( ), and 24 ( ) h
as described under ``Experimental Procedures.'' Results for
discoidal rHDL with SPM/apoA-I molar ratios of 0/1, 13.6/1, and 26.3/1
are shown in Panels A, B, and C,
respectively. Results for spherical rHDL with SPM/apoA-I molar ratios
of 0/1 and 4.9/1 are shown in Panels D and E,
respectively. The data in Panel F represents lipid-free
apoA-I. Each data point represents the mean of triplicate
determinations. Experimental errors for the wavelength of maximum
fluorescence are ± 1.0 nm.
Figure 5:
Influence of SPM on the kinetics of
unfolding of apoA-I in discoidal and spherical rHDL. Discoidal rHDL
with SPM/apoA-I molar ratios of 0/1 ( ), 13.6/1 ( ), and
26.3/1 ( ), spherical rHDL with SPM/apoA-I molar ratios of 0/1
( ) and 4.9/1 ( ) and lipid-free apoA-I ( ) were
incubated for 0-24 h with 2.5 M GdnHCl. Values for the
wavelength of maximum fluorescence represent the mean of triplicate
determinations. Experimental errors are ±1.0
nm.
Lipid-free apoA-I unfolded rapidly and
completely, as evidenced by the comparable wavelengths of maximum
fluorescence at 0, 2, and 24 h (Fig. 4F). The
wavelengths of maximum fluorescence for the discoidal and spherical
rHDL (Fig. 4, A-E) were blue-shifted at 0 and 2 h
relative to 24 h, confirming that unfolding of apoA-I is inhibited by
lipid association(23, 35) . Fig. 5shows the
kinetics of the unfolding of apoA-I at 2.5 M GdnHCl. The
apoA-I in the spherical rHDL which had been incubated with
sphingomyelinase (closed circles) unfolded more rapidly than
the apoA-I in the spherical rHDL which had been incubated with TBS (open circles). The rate of unfolding of apoA-I in discoidal
rHDL decreased as the molar ratio of SPM/apoA-I increased from 0/1 (open squares) to 13.6/1 (closed diamonds) to 26.3/1 (open diamonds). Taken together, these results suggest that
the SPM head group may be partly responsible for inhibiting the
unfolding of apoA-I in discoidal rHDL. It should also be noted that,
irrespective of the SPM content of the particles, the apoA-I in
spherical rHDL unfolds more rapidly than the apoA-I in discoidal rHDL. The influence of SPM on apoA-I stability was assessed from the
concentration of GdnHCl required for 50% unfolding of apoA-I
([GdnHCl] ). Values for
[GdnHCl] were determined directly from the 24-h
denaturation curves in Fig. 4and calculated as described under
``Experimental Procedures.'' The results in Table 2show good agreement between the two approaches.
[Gdn-HCl] for lipid-free apoA-I was 1.0 M, confirming what has been reported elsewhere(36) .
[GdnHCl] for the discoidal rHDL increased with
the molar ratio of SPM/apoA-I, suggesting that the stability of apoA-I
is enhanced by the SPM molecule. When the spherical rHDL were incubated
with sphingomyelinase, [GdnHCl] was not
affected. In other words, SPM head groups do not influence the
stability of apoA-I in spherical rHDL. Although
[GdnHCl] increased when the apoA-I was
associated with lipid, this change does not necessarily translate into
an increase in the stability of apoA-I. For example, although
[GdnHCl] for apoA-I in spherical rHDL is
greater than that of lipid-free apoA-I, the two preparations have
similar conformational stabilities
( G
Influence of SPM on the Lipid Transfers Mediated by CETP (Fig. 6)To determine whether SPM influences
CETP-mediated transfers of CE and triglyceride (TG), spherical rHDL
were preincubated with TBS (Fig. 6, open symbols) or
sphingomyelinase (closed symbols), reisolated by
ultracentrifugation, then incubated with CETP and Intralipid for
0-24 h. Panels A and B, respectively, show the
concentrations of CE and TG in the rHDL. Panel C shows the
total core lipid concentration (CE + TG) of the
rHDL. CETP mediated the transfer of CE from rHDL to Intralipid as
evidenced by the time-dependent decrease in the concentration of rHDL
CE (Panel A). The concentration of rHDL TG increased during
the first 3 h of incubation and decreased thereafter, as reported
previously (23) (Panel B). The net result of these
transfers was a progressive decrease in the concentration of rHDL core
lipids (Panel C). During the incubation the diameter of the
rHDL decreased from 8.6 to 8.0 nm, and lipid-free apoA-I dissociated
from the particles (results not shown). The reduction in rHDL size and
dissociation of apoA-I, which have been described
elsewhere(23) , were not influenced by preincubation with
sphingomyelinase.
Figure 6:
Influence of SPM on the CETP-mediated
transfer of core lipids between spherical rHDL and Intralipid.
Spherical rHDL were incubated with sphingomyelinase or TBS and
reisolated by ultracentrifugation as described under
``Experimental Procedures.'' Their composition is shown in Table 1. They were then incubated with TBS, TBS and Intralipid,
or TBS, Intralipid, and CETP for 0, 1, 3, 6, 12, or 24 h. The final
concentrations of rHDL CE and Intralipid TG (if present) in the
incubation mixtures were 0.1 and 3.9 mmol/liter, respectively. The
final activity of CETP (if present) was 2.6 units/ml. The final volume
of the incubation mixtures was 2.0 ml. When the incubations were
complete, the rHDL were isolated by ultracentrifugation in the 1.063
< d < 1.25 g/ml density range as described under
``Experimental Procedures.'' Concentrations of rHDL CE (Panel A), rHDL TG (Panel B), and rHDL CE + TG (Panel C) are shown. Values in Panels A and B represent the mean of triplicate determinations which varied by
10% or less.
Influence of SPM on the LCAT Reaction (Fig. 7)Aliquots of discoidal rHDL with
POPC/SPM/UC/apoA-I molar ratios of 97.7/0.0/9.6/1.0 and
69.8/26.2/9.8/1.0 were incubated with purified LCAT for 5, 10, 15, 20,
and 30 min. The nanomoles of CE generated in the discoidal rHDL with (Fig. 7, open symbols) and without SPM (closed
symbols) is shown. At each time point there was less cholesterol
esterification in the SPM-containing rHDL. This confirms what has been
reported elsewhere(26) . Comparable results were obtained when
the experiment was repeated using discoidal rHDL with SPM/apoA-I molar
ratios of 0/1 and 26/1 and UC/apoA-I molar ratios of 2/1, 4/1, and 6/1
(results not shown).
Figure 7:
Influence of SPM on the LCAT reaction in
discoidal rHDL. Discoidal rHDL with POPC/SPM/UC/apoA-I molar ratios of
97.7/0.0/9.6/1.0 and 69.8/26.2/9.8/1.0 were prepared by cholate
dialysis. Both preparations were radiolabeled with
[ H]UC as described under ``Experimental
Procedures.'' Aliquots of each preparation which contained 3.25
nmol UC were incubated at 37 °C for 5, 10, 15, 20, or 30 min with
purified LCAT. Esterification of cholesterol in the rHDL with ( )
and without ( ) SPM is shown. The data points represent the mean
± S.D. of triplicate determinations. *p <
0.05,**p < 0.005
DISCUSSION
SPM, a glycosphingolipid consisting of a ceramide backbone
and phosphocholine head group, is present in most cell membranes. SPM
is transported in the plasma as a component of lipoproteins, but its
impact on lipoprotein metabolism, and on HDL metabolism in particular,
is poorly understood. This issue is addressed in the present study.
Specifically we have determined how the SPM molecule and its head group
influence the structure and function of discoidal and spherical rHDL. To assess the influence of the SPM head group on rHDL metabolism,
the rHDL were incubated with sphingomyelinase. Interpretation of these
studies was dependent on sphingomyelinase affecting neither rHDL size
nor the concentrations of other rHDL constituents. This was achieved
for spherical rHDL ( Fig. 1and Table 1). The discoidal
rHDL, by contrast, were converted into larger and smaller particles
during incubation with sphingomyelinase (data not shown). This is not
consistent with what has been reported by Subbaiah and
Lui(26) , who found that the size of discoidal rHDL was not
affected by incubation with sphingomyelinase. Given that the rHDL
described by Subbaiah and Lui contained egg PC, as opposed to POPC in
the present studies, it is possible that this discrepancy may be due to
the structural differences between the two phospholipids. As egg PC has
a higher proportion of unsaturated acyl chains than POPC(37) ,
it follows that egg PC-containing discoidal rHDL will have less ordered
phospholipid acyl chains and more hydrated interfacial regions than
POPC-containing discoidal rHDL(38) . Given that electrostatic
repulsions between phospholipid head groups decrease as hydration of
lipid bilayers increases(39) , it is possible that rHDL which
contain egg PC may be more stable, and resistant to size changes, than
rHDL which contain POPC. Regardless of the mechanism, the fact that
sphingomyelinase altered the size of the POPC-containing discoidal rHDL
precluded investigation of the influence of SPM head groups on their
structure. The problem of sphingomyelinase-mediated changes to the
size of discoidal rHDL was circumvented by investigating the influence
of the entire SPM molecule on their structure and function. To this end
discoidal rHDL were prepared with a range of concentrations of SPM. The
phospholipid/apoA-I molar ratio in these rHDL was maintained at
approximately 100/1 by appropriate reductions in the concentration of
POPC (Table 1). The rHDL size was not affected as the SPM/POPC
molar ratio increased from 0/1 to 0.4/1 (Fig. 1). This differs
from what has been reported by Subbaiah and Lui(26) , who found
that the diameter of discoidal rHDL with egg PC increased from 10.0 to
16.8 nm when the SPM/egg PC molar ratio increased from 0/1 to 0.5/1.
This discrepancy can be explained if the concentration of egg PC was
not decreased when SPM was introduced into the rHDL. Under these
circumstances the phospholipid/apoA-I molar ratio of the rHDL would
increase and the particles would increase in size(40) . It is
also possible that the increase in rHDL size was due to the somewhat
disordered egg PC acyl chains being unable to accommodate the
asymmetric SPM molecule. Under these circumstances the rHDL may undergo
a structural reorganization to form larger, more stable particles. The polarization results in Fig. 3show that SPM increases
the packing order of phospholipid acyl chains and head groups in
discoidal rHDL. This is probably because the SPM interfacial region
contains a C4-C5 trans double bond which has been
reported to increase acyl chain packing order(4) . The results
in Fig. 3also show that the SPM head group has a slight
ordering effect on the acyl chains in spherical rHDL. When these
results are taken together it is tempting to speculate that the SPM
head group is partly responsible for increasing the acyl chain packing
order in discoidal rHDL. However, this is not necessarily the case as
DPH partitions differently in discoidal and spherical rHDL. In
spherical HDL, DPH is located at the interface of the phospholipid acyl
chains and neutral lipid core(41) . In discoidal rHDL, DPH
intercalates between phospholipid acyl chains(42) . The
results of the PRODAN studies (Fig. 3C) show that
neither the SPM molecule nor its head group affect the hydration of
rHDL lipid-water interfacial regions at temperatures less than 25
°C. This is in agreement with the report of Jonas et
al.(35) . Above 25 °C, by contrast, there is a
pronounced increase in discoidal rHDL lipid-water interfacial hydration
which becomes less apparent as the concentration of SPM increases. This
suggests that SPM limits the access of water to the discoidal rHDL
lipid-water interface and is consistent with the observation that
SPM-containing lipid bilayers have a low permeability to
water(43) . The additional finding, that above 25 °C,
spherical rHDL have less hydrated lipid-water interfaces than discoidal
rHDL, suggests that access of water to the surface of spherical rHDL is
restricted. This may occur if a proportion of the phospholipid head
groups on the surface of spherical rHDL is masked by apoA-I. Finally,
as incubation of spherical rHDL with sphingomyelinase does not affect
the wavelength of maximum fluorescence of PRODAN, it follows that the
SPM head group does not influence the interfacial hydration of these
particles. One of the most unexpected findings to emerge from the
present study is that SPM transfers rapidly and spontaneously between
LDL and rHDL with a t = 0.8 h. The t for the spontaneous transfer of
phosphatidylcholine mass between discoidal rHDL and LDL, by contrast,
ranges from 5.8 to 6.9 h(44) . This marked difference in
half-times probably reflects structural differences between SPM and
phosphatidylcholine. The interfacial region of SPM is polar and
contains a trans double bond, a free hydroxyl group, and an
amide bond(4) . This region interacts strongly with water and
is probably responsible for the rapid transfer of SPM. The
corresponding region of phosphatidylcholine, by contrast, comprises a
glycerol backbone and possibly the carbonyl portion of the ester bonds.
These regions neither interact with water nor facilitate the
spontaneous transfer of phosphatidylcholines. A primary aim of the
present study was to determine how SPM influences the metabolism of
HDL. The finding that SPM inhibits the LCAT-mediated esterification of
UC in discoidal rHDL (Fig. 7) confirms what has been reported
elsewhere(26) . This reduction in cholesterol esterification
has been attributed to competition between SPM and phospholipids for
binding to the active site of LCAT(26) . Our results also show
that CETP-mediated transfers of CE and TG between spherical rHDL and
Intralipid are not affected when the rHDL are depleted of SPM head
groups (Fig. 6). As CETP reportedly binds to phospholipid head
groups on the surface of HDL(45) , this result suggests that
the concentration of phospholipids is not rate-limiting for
CETP-mediated transfers of core lipids. When spherical rHDL are
subjected to agarose gel electrophoresis they migrate slower than
native HDL (Table 1). This difference in mobility, which reflects
the different surface charges of the preparations, is most likely due
to variations in apolipoprotein and phospholipid composition. Native
HDL contain several classes of apolipoproteins (46) , whereas
the rHDL used in the present study contain only apoA-I. Davidson et
al.(13) have also shown that phospholipid acyl chain
composition affects HDL surface charge. As native HDL contain a range
of phospholipids(47) , it is to be expected that their surface
charge differs from that of rHDL which contain only POPC. When
spherical rHDL are depleted of SPM head groups, their mobility is
indistinguishable from that of native HDL. In other words, removing the
SPM head group increases the negative charge on the surface of rHDL.
One explanation for this observation is that removing the SPM head
group exposes the polar, interfacial region of the molecule and that
this region influences the surface charge of rHDL. Alternatively, it is
possible that the conformation of apoA-I changes when spherical rHDL
are depleted of SPM head groups. However, given that rHDL size is not
affected by incubation with sphingomyelinase (Fig. 1), and the
conformation of apoA-I is dependent on rHDL size(48) , this is
not likely. The finding that SPM decreases the GdnHCl-mediated
unfolding of apoA-I in discoidal rHDL (Fig. 5) confirms what has
been reported by Swaney (49) . This decrease may be due to the
hydrogen bonds in the SPM interfacial region enhancing
apoA-I-phospholipid interactions and stabilizing the particles. The
additional finding that incubation with sphingomyelinase increases the
unfolding of apoA-I in spherical rHDL suggests that SPM head groups
also enhance phospholipid-apoA-I interactions. An alternative
explanation for the increased unfolding of apoA-I in spherical rHDL is
that removal of SPM head groups alters the orientation of
phosphocholine head groups. Scherer and Seelig have shown that the
orientation of these head groups is sensitive to surface
charge(50) . As the negative charge on the surface of spherical
rHDL increases after incubation with sphingomyelinase (Table 1),
it follows that phosphocholine head group orientation may be altered
such that phospholipid-apoA-I interactions decrease and the rHDL are
destabilized. In summary, this study provides an insight into the
effect of SPM on the structure and function of discoidal and spherical
rHDL. We have shown that the SPM molecule, and its head group,
influence the structure and stability of both types of rHDL. When these
results are considered, together with the observation that SPM inhibits
cholesterol esterification in discoidal rHDL, it follows that factors
which regulate the concentration of SPM in HDL may have a significant
impact on plasma cholesterol transport.
FOOTNOTES
- *
- This work
was supported by the National Health and Medical Research Council of
Australia and the Ramaciotti Foundation. The costs of publication of
this article were defrayed in part by the payment of page charges. This
article must therefore by hereby marked
``advertisement'' in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
- §
- To whom correspondence should be addressed:
Lipid Research Laboratory, Level 1, Hanson Centre, Frome Road,
Adelaide, South Australia, Australia 5000. Tel.: 61-8-222-3448; Fax:
61-8-223-3870.
- (
) - The abbreviations used are: SPM,
sphingomyelin; HDL, high density lipoprotein(s); LDL, low density
lipoprotein(s); rHDL, reconstituted high density lipoproteins; PC,
phosphatidylcholine; POPC, 1-palmitoyl-2-oleoyl phosphatidylcholine;
UC, unesterified cholesterol; CE, cholesteryl ester(s); apo,
apolipoprotein; LCAT, lecithin:cholesterol acyltransferase; CETP,
cholesteryl ester transfer protein; TBS, Tris-buffered saline; TG,
triglyceride; DPH, 1,6-diphenyl-1,3,5-hexatriene; TMA-DPH
1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluene sulfonate; PRODAN,
6-propionyl-2-(dimethylamino)-naphthalene; GdnHCl, guanidine
hydrochloride.
REFERENCES
- Hannun, Y. A.,
and Obeid, L. M. (1995) Trends Biochem. Sci. 20, 73-77
[CrossRef][Medline]
[Order article via Infotrieve]
- Hannun, Y. A., and
Linardic, C. M. (1993) Biochim. Biophys. Acta 1154, 223-226
[Medline]
[Order article via Infotrieve]
- Hannun, Y. A. (1994) J. Biol. Chem. 269, 3125-3128
[Free Full Text]
- Barenholz, Y., and Gatt, S.
(1982) in Phospholipids (Hawthorn, J. N., and Ansell, G. B.,
eds) pp. 129-177, Elsevier Biomedical Press, Amsterdam
- Kawano, M., Miida, T.,
Fielding, C. J., and Fielding, P. E. (1993) Biochemistry 32, 5025-5028
[CrossRef][Medline]
[Order article via Infotrieve]
- Winkler, K. E., and
Marsh, J. B. (1989) J. Lipid Res. 30, 979-987
[Abstract]
- Reichl, D., and Sterchi,
J. M. (1992) Biochim. Biophys. Acta 1127, 28-32
[Medline]
[Order article via Infotrieve]
- Kan, C.-C., Ruan, Z.-s.,
and Bittman, R. (1991) Biochemistry 30, 7759-7766
[CrossRef][Medline]
[Order article via Infotrieve]
- McIntosh, T. J., Simon,
S. A., Needham, D., and Huang, C.-h. (1992) Biochemistry 31, 2012-2020
[CrossRef][Medline]
[Order article via Infotrieve]
- Pörn,
M. I., Ares, M. P. S., and Slotte, J. P. (1993) J.
Lipid Res. 34, 1385-1392
[Abstract]
- Xu, X.-X., and Tabas, I. (1991) J. Biol. Chem. 266, 24849-24858
[Abstract/Free Full Text]
- Gupta, A. K., and
Rudney, H. (1992) J. Lipid Res. 33, 1741-1752
[Abstract]
- Davidson, W. S.,
Gillotte, K. L., Lund-Katz, S., Johnson, W. J., Rothblat, G. H., and
Phillips, M. C. (1995) J. Biol. Chem. 270, 5882-5890
[Abstract/Free Full Text]
- Rye, K.-A. (1990) Biochim. Biophys. Acta 1042, 227-236
[Medline]
[Order article via Infotrieve]
- Rye, K.-A., and Barter,
P. J. (1994) J. Biol. Chem. 269, 10298-10303
[Abstract/Free Full Text]
- Rye, K.-A., Garrety, K.
H., and Barter, P. J. (1992) J. Lipid Res. 33, 215-224
[Abstract]
- Osborne, J. C., Jr. (1986) Methods Enzymol. 128A, 213-222
[Medline]
[Order article via Infotrieve]
- Weisweiler, P. (1987) Clin. Chim. Acta 169, 249-254
[CrossRef][Medline]
[Order article via Infotrieve]
- Matz, C. E., and Jonas,
A. (1982) J. Biol. Chem. 257, 4535-4540
[Abstract/Free Full Text]
- Rye, K.-A., Garrety, K.
H., and Barter, P. J. (1993) Biochim. Biophys. Acta 1167, 316-325
[Medline]
[Order article via Infotrieve]
- Mahadevan, V., and
Soloff, L. A. (1983) Biochim. Biophys. Acta 752, 89-97
[Medline]
[Order article via Infotrieve]
- Piran, U., and Morin, R.
J. (1979) J. Lipid Res. 20, 1040-1043
[Abstract]
- Rye, K.-A., Hime, N. J.,
and Barter, P. J. (1995) J. Biol. Chem. 270, 189-196
[Abstract/Free Full Text]
- Tollefson, J. H., Lui,
A., and Albers, J. J. (1988) Am. J. Physiol. 255, E894-E902
- Burstein, M., Scholnick,
H. R., and Morfin, R. (1970) J. Lipid Res. 11, 583-595
[Abstract]
- Subbaiah, P., and Lui,
M. (1993) J. Biol. Chem. 268, 20156-20163
[Abstract/Free Full Text]
- Sparks, D. L., and
Phillips, M. C. (1992) J. Lipid Res. 33, 123-130
[Abstract]
- Rye, K.-A. (1989) J. Lipid Res. 30, 335-346
[Abstract]
- Lentz, B. R., Barenholz,
Y., and Thompson, T. E. (1976) Biochemistry 15, 4521- 4528
[CrossRef][Medline]
[Order article via Infotrieve]
- Prendergast, F. G.,
Haugland, R. P., and Callahan, P. J. (1981) Biochemistry 20, 7333-7338
[CrossRef][Medline]
[Order article via Infotrieve]
- Weber, G., and Farris,
F. J. (1979) Biochemistry 18, 3075-3078
[CrossRef][Medline]
[Order article via Infotrieve]
- Pace, N. C. (1986) Methods Enzymol. 131, 266-280
[Medline]
[Order article via Infotrieve]
- Hopkins, G. J., and
Barter, P. J. (1989) Atherosclerosis 75, 73-82
[CrossRef][Medline]
[Order article via Infotrieve]
- Bradley, C. A., Salhany,
K. E., Entman, S. S., Aleshire, S. L., and Parl, F. F. (1987) Clin. Chem. 33, 81-86
[Abstract/Free Full Text]
- Jonas, A., Wald, J. H.,
Toohill, K. L. H., Krul, E. S., and Kézdy, K. E. (1990) J. Biol. Chem. 265, 22123-22129
[Abstract/Free Full Text]
- Sparks, D. L., Davidson,
W. S., Lund-Katz, S., and Phillips, M. C. (1993) J.
Biol. Chem. 268, 23250-23257
[Abstract/Free Full Text]
- Kuksis, A. (1992) Biochim. Biophys. Acta 1124, 205-222
[Medline]
[Order article via Infotrieve]
- Straume, M., and Litman,
B. J. (1987) Biochemistry 26, 5113-5120
[CrossRef][Medline]
[Order article via Infotrieve]
- Slater, S. J., Ho, C.,
Taddeo, F. J., Kelly, M. B., and Stubbs, C. D. (1993) Biochemistry 32, 3714-3721
[CrossRef][Medline]
[Order article via Infotrieve]
- Wetterau, J. R., and
Jonas, A. (1983) J. Biol. Chem. 258, 2637-2643
[Free Full Text]
- Ben-Yashar, V., and
Barenholz, Y. (1991) Chem. Phys. Lipids 60, 1-14
[CrossRef][Medline]
[Order article via Infotrieve]
- Lentz, B. R. (1989) Chem. Phys. Lipids 50, 171-190
[CrossRef]
- Barenholz, Y., and
Thompson, T. E. (1980) Biochim. Biophys. Acta 604, 129-158
[Medline]
[Order article via Infotrieve]
- Jonas, A.,
Kézdy, K. E., Williams, M. I., and Rye, K.-A. (1988) J. Lipid Res. 29, 1349-1357
[Abstract]
- Pattnaik, N. M., and
Zilversmit, D. B. (1979) J. Biol. Chem. 254, 2782-2786
[Free Full Text]
- Eisenberg, S. (1984) J. Lipid Res. 25, 1017-1058
[Medline]
[Order article via Infotrieve]
- Scanu, A. M. (1979) in The Biochemistry of Atherosclerosis (Scanu, A. M., ed) pp.
3-8, Marcel Dekker, New York
- Jonas, A.,
Kézdy, K. E., and Wald, J. H. (1989) J. Biol. Chem. 264, 4818-4824
[Abstract/Free Full Text]
- Swaney, J. B. (1983) J. Biol. Chem. 258, 1254-1259
[Abstract/Free Full Text]
- Scherer, P. G., and
Seelig, J. (1989) Biochemistry 28, 7720-7728
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Skropeta, C. Settasatian, M. R. McMahon, K. Shearston, D. Caiazza, K. C. McGrath, W. Jin, D. J. Rader, P. J. Barter, and K.-A. Rye
N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins
J. Lipid Res.,
September 1, 2007;
48(9):
2047 - 2057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, J. A. de Souza, S. Chantepie, and M. J. Chapman
Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2007;
27(8):
1843 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Singh and P. V. Subbaiah
Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids
J. Lipid Res.,
March 1, 2007;
48(3):
683 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Rye, R. Bright, M. Psaltis, and P. J. Barter
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
J. Lipid Res.,
May 1, 2006;
47(5):
1025 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. Lee, A. Lesimple, M. Denis, J. Vincent, A. Larsen, O. Mamer, L. Krimbou, J. Genest, and M. Marcil
Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B
J. Lipid Res.,
March 1, 2006;
47(3):
622 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nilsson and R.-D. Duan
Absorption and lipoprotein transport of sphingomyelin
J. Lipid Res.,
January 1, 2006;
47(1):
154 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest
Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines
J. Lipid Res.,
August 1, 2005;
46(8):
1668 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. Lee, A. Lesimple, A. Larsen, O. Mamer, and J. Genest
ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDL
J. Lipid Res.,
June 1, 2005;
46(6):
1213 - 1228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jahangiri, D. J. Rader, D. Marchadier, L. K. Curtiss, D. J. Bonnet, and K-A. Rye
Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I
J. Lipid Res.,
May 1, 2005;
46(5):
896 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Rye and P. J. Barter
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2004;
24(3):
421 - 428.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K.-A. Rye, K. Wee, L. K. Curtiss, D. J. Bonnet, and P. J. Barter
Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation
J. Biol. Chem.,
June 13, 2003;
278(25):
22530 - 22536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Rye and M. N. Duong
Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high density lipoproteins
J. Lipid Res.,
October 1, 2000;
41(10):
1640 - 1650.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. G. Frank and Y. L. Marcel
Apolipoprotein A-I: structure;-function relationships
J. Lipid Res.,
June 1, 2000;
41(6):
853 - 872.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. A. Clay, D. H. Pyle, K.-A. Rye, and P. J. Barter
Formation of Spherical, Reconstituted High Density Lipoproteins Containing Both Apolipoproteins A-I and A-II Is Mediated by Lecithin:Cholesterol Acyltransferase
J. Biol. Chem.,
March 17, 2000;
275(12):
9019 - 9025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vesper, E.-M. Schmelz, M. N. Nikolova-Karakashian, D. L. Dillehay, D. V. Lynch, and A. H. Merrill Jr.
Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition
J. Nutr.,
July 1, 1999;
129(7):
1239 - 1250.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. W. Baker, K.-A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter
Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells
J. Lipid Res.,
February 1, 1999;
40(2):
345 - 353.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. J. Hime, P. J. Barter, and K.-A. Rye
The Influence of Apolipoproteins on the Hepatic Lipase-mediated Hydrolysis of High Density Lipoprotein Phospholipid and Triacylglycerol
J. Biol. Chem.,
October 16, 1998;
273(42):
27191 - 27198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Arimoto, H. Saito, Y. Kawashima, K. Miyajima, and T. Handa
Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions
J. Lipid Res.,
January 1, 1998;
39(1):
143 - 151.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K.-A. Rye, N. J. Hime, and PhilipJ. Barter
Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion
J. Biol. Chem.,
February 14, 1997;
272(7):
3953 - 3960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sviridov, L. E. Pyle, and N. Fidge
Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants
J. Biol. Chem.,
December 27, 1996;
271(52):
33277 - 33283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Bolin and A. Jonas
Sphingomyelin Inhibits the Lecithin-Cholesterol Acyltransferase Reaction with Reconstituted High Density Lipoproteins by Decreasing Enzyme Binding
J. Biol. Chem.,
August 9, 1996;
271(32):
19152 - 19158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Panzenbock, L. Kritharides, M. Raftery, K.-A. Rye, and R. Stocker
Oxidation of Methionine Residues to Methionine Sulfoxides Does Not Decrease Potential Antiatherogenic Properties of Apolipoprotein A-I
J. Biol. Chem.,
June 23, 2000;
275(26):
19536 - 19544.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|